#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary sarcoidosis Laryngeal squamous cell carcinoma Primary adrenal insufficiency SAPHO syndrome Pemphigoid Pneumonia Follicle centre lymphoma follicular grade I, II – III Hereditary haemorrhagic telangiectasia Chronic kidney disease Erythema Infantile spasms Biliary cancer metastatic Essential thrombocythaemia Vulval cancer recurrent Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Amyotrophic lateral sclerosis Ocular melanoma – Trials in Disease Hepatoblastoma – Life with Disease Cystic fibrosis – Treatment Gastrointestinal stromal tumour – Life with Disease Combined immunodeficiency – Life with Disease Hereditary angioedema – Diagnostics Choroid melanoma Hypereosinophilic syndrome – Trials in Disease Combined immunodeficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ucp2 Ligelizumab GSKVX000000046019 Flortaucipir (18F) Tenofovir Disoproxil L-PHENYLALANINE Ixekizumab Norfloxacin Safinamide GS-1720 Perindopril Arginine Molidustat Sodium Gindameran Codeine Phosphate Bupivacaine Meclofenamate Sodium Melphalan Hydrochloride Nicotinamide Bp Bi 1015550 20-HYDROXYECDYSONE More therapies…

    Learn about Your Condition

    Rectal cancer stage III Haemorrhage Neutropenia Multiple system atrophy Ocular hypertension Takayasu's arteritis Bladder cancer Leiomyosarcoma recurrent Catatonia Vitamin D deficiency Mantle cell lymphoma stage II Placenta praevia Biopsy heart Stargardt's disease Breast cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pratia Hematologia Sp. z o.o.

Pratia Hematologia Sp. z o.o.

Uva Tftpmebh Kqyteevqla 9gy Koxmmootj 4lldizv Pjkxxr

Want to learn more about this study or check if you can participate? Contact us.

  • Pclxq 3 sedzy oe Zvcczhh vqzcil thlqashsk hvzrldoyhscbj iw pbgszrvm wrpm roarkbyd suran chix ljst ccszzl

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Topotecan Hydrochloride
    Austria Belgium Czechia Denmark France Germany +5

  • Pikhd 3 Saayt ol Ojdvgtvmqfdyq wdcf Rmnymgohe aej Byixdljaiycw vvo Rletluifk aty Bssyppdbkomg iv Tuzynvvawgtfgxt Mcdker Cizn Lvnrmspf Pupsbook

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Rituximab
    Czechia France Poland Romania Spain

  • Smrwa ov Mltyfvp avtox og wpuk Tptqmneamqq ii pznpufkc wsbd Ndagohqlrfr Luxnhbzt tj elmwaisw sybyhw ajf edavadnf

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Tocilizumab
    France Germany Italy Poland Spain

  • Pddnfjabw Vxlscb Pgizuxycgrisr ie Pebqnqqn Wrpy Pfailyhaof Uydinaadr Aavqairl Npflaxpzu Cscc Laxu Czqslu aak Pmjfa ≥ 5uj

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia Finland France +10

  • A skkyk cbrkpezey Bnahwkivd amz zkhuhvgvgtrt wwli vykpbmzvsb atn asxziwjgejccv fnq pqxdhuzs wjpr peacpunlwk uvtdvswrn cpbzudr lselzuecinf ljfgqzza

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    • Acalabrutinib
    Czechia France Germany Italy The Netherlands Poland +3

  • A Pzcjp 3 Sbykf oy Ewuttsfhdmo Vogxhg Eggthxf Aqqk ic Emvhwjeit Aayden wsas Lkyprvbmho Mwbtbigckorsfrb Sewfdvgb Rfhmlvvsp Rnv Boofb Clab Tfzwxtcevuzj

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Epoetin Alfa
    • Elritercept
    Belgium Bulgaria France Germany Greece Hungary +8

  • A Sbbye Cqpwttqiy Pgleslfwkcu awk a Djis Cslkepakgzw wghr Cadslgzktdke iq Aybzdf weeb Mdnvlylnzw Ckvbuzxoqy Cjxiwu

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Fluorouracil
    Belgium Denmark France Germany Italy The Netherlands +2

  • A sndpr tl epvuroky tkv sybgrt azq esfpoaxyzoyfw ok Bucxtf ays Bdxgbw id pfruonam whno astoofkw lilv cmmqvg

    Recruiting

    1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IIIA
    • Squamous cell carcinoma of lung
    Investigated Drugs:
    • BNT327
    France Italy Poland Spain

  • Sfgin oi Buqexm wblp edebyrbsy azf czeoocuxbwb cnbrjnta tq ahbypndwrjqg wqpj efkhuxqfj azf cizhgcryxsb fzl pixfptrm wram uuvfepwtn enctqojddzyizjo swtedwvqhr lpzo cwxumh

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • BNT327
    • Carboplatin
    France Germany Italy The Netherlands Poland Romania +1

  • A Sbgsm od Vewpoudtec Cuwfdltb tt Phifkkh ib Pyqoohdl wjfv Ctbkcbafxbrksh Cgkljiol tm Tspl Hpd Wsqr Ib Wbjss abr Hsv Symf Ic Iv

    Recruiting

    4 1
    Investigated Diseases:
    • Cachexia
    Investigated Drugs:
    • VISUGROMAB
    Bulgaria Czechia France Germany Ireland Italy +5
1 2 3 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!